Literature DB >> 27890388

Uganda experience-Using cost assessment of an established registry to project resources required to expand cancer registration.

Henry Wabinga1, Sujha Subramanian2, Sarah Nambooze1, Phoebe Mary Amulen1, Patrick Edwards3, Rachael Joseph4, Martin Ogwang5, Francis Okongo5, D Maxwell Parkin6, Florence Tangka7.   

Abstract

BACKGROUND: The objectives of this study are (1) to estimate the cost of operating the Kampala Cancer Registry (KCR) and (2) to use cost data from the KCR to project the resource needs and cost of expanding and sustaining cancer registration in Uganda, focusing on the recently established Gulu Cancer Registry (GCR) in rural Northern Uganda.
METHODS: We used Centers for Disease Control and Prevention's (CDC's) International Registry Costing Tool (IntRegCosting Tool) to estimate the KCR's activity-based cost for 2014. We grouped the registry activities into fixed cost, variable core cost, and variable other cost activities. After a comparison KCR and GCR characteristics, we used the cost of the KCR to project the likely ongoing costs for the new GCR.
RESULTS: The KCR incurred 42% of its expenditures in fixed cost activities, 40% for variable core cost activities, and the remaining 18% for variable other cost activities. The total cost per case registered was 28,201 Ugandan shillings (approximately US $10 in 2014) to collect and report cases using a combination of passive and active cancer data collection approaches. The GCR performs only active data collection, and covers a much larger area, but serves a smaller population compared to the KCR.
CONCLUSION: After identifying many differences between KCR and GCR that could potentially affect the cost of registration, our best estimate is that the GCR, though newer and in a rural area, should require fewer resources than the KCR to sustain operations as a stand-alone entity. The optimal structure of the GCR needs to be determined in the future.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activity-based cost; Economic evaluation; Gulu Cancer Registry; Kampala Cancer Registry; Uganda

Mesh:

Year:  2016        PMID: 27890388      PMCID: PMC5840874          DOI: 10.1016/j.canep.2016.11.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  16 in total

1.  Economic assessment of central cancer registry operations. Part II: developing and testing a cost assessment tool.

Authors:  Sujha Subramanian; Florence Tangka; Jeremy Green; Hannah Weir; Frances Michaud
Journal:  J Registry Manag       Date:  2009

2.  Completeness in an African cancer registry.

Authors:  D M Parkin; H Wabinga; S Nambooze
Journal:  Cancer Causes Control       Date:  2001-02       Impact factor: 2.506

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Developing and testing a cost data collection instrument for noncommunicable disease registry planning.

Authors:  Sujha Subramanian; Florence Tangka; Patrick Edwards; Sonja Hoover; Maggie Cole-Beebe
Journal:  Cancer Epidemiol       Date:  2016-10-07       Impact factor: 2.984

5.  Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study.

Authors:  Sam M Mbulaiteye; Elly T Katabira; Henry Wabinga; Donald M Parkin; Phillip Virgo; Robert Ochai; Meklit Workneh; Alex Coutinho; Eric A Engels
Journal:  Int J Cancer       Date:  2006-02-15       Impact factor: 7.396

6.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

7.  Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.

Authors:  E Chokunonga; M Z Borok; Z M Chirenje; A M Nyakabau; D M Parkin
Journal:  Int J Cancer       Date:  2013-03-04       Impact factor: 7.396

8.  The cost of cancer registry operations: Impact of volume on cost per case for core and enhanced registry activities.

Authors:  Sujha Subramanian; Florence K L Tangka; Maggie Cole Beebe; Diana Trebino; Hannah K Weir; Frances Babcock
Journal:  Eval Program Plann       Date:  2015-11-30

9.  Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005.

Authors:  P Ocama; S Nambooze; C K Opio; M S Shiels; H R Wabinga; G D Kirk
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

10.  Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.

Authors:  H Wabinga; A V Ramanakumar; C Banura; A Luwaga; S Nambooze; D M Parkin
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more
  2 in total

Review 1.  Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Authors:  Wilfred Ngwa; Beatrice W Addai; Isaac Adewole; Victoria Ainsworth; James Alaro; Olusegun I Alatise; Zipporah Ali; Benjamin O Anderson; Rose Anorlu; Stephen Avery; Prebo Barango; Noella Bih; Christopher M Booth; Otis W Brawley; Jean-Marie Dangou; Lynette Denny; Jennifer Dent; Shekinah N C Elmore; Ahmed Elzawawy; Diane Gashumba; Jennifer Geel; Katy Graef; Sumit Gupta; Serigne-Magueye Gueye; Nazik Hammad; Laila Hessissen; Andre M Ilbawi; Joyce Kambugu; Zisis Kozlakidis; Simon Manga; Lize Maree; Sulma I Mohammed; Susan Msadabwe; Miriam Mutebi; Annet Nakaganda; Ntokozo Ndlovu; Kingsley Ndoh; Jerry Ndumbalo; Mamsau Ngoma; Twalib Ngoma; Christian Ntizimira; Timothy R Rebbeck; Lorna Renner; Anya Romanoff; Fidel Rubagumya; Shahin Sayed; Shivani Sud; Hannah Simonds; Richard Sullivan; William Swanson; Verna Vanderpuye; Boateng Wiafe; David Kerr
Journal:  Lancet Oncol       Date:  2022-05-09       Impact factor: 54.433

2.  Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs.

Authors:  Sonja Hoover; Sujha Subramanian; Florence Tangka
Journal:  Prev Chronic Dis       Date:  2019-05-02       Impact factor: 2.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.